IDEXX LABORATORIES INC /DE

10-K & 10-Q Filings

IDEXX Laboratories, Inc. is a Delaware corporation incorporated in 1983. The company develops, manufactures, and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing industries. IDEXX's business strategy includes enhancing the health and well-being of pets, people, and livestock through innovative diagnostic solutions and services. The company operates through three business segments: Companion Animal Group (CAG), Water quality products, and Livestock, Poultry and Dairy (LPD). CAG offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Water provides innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. LPD offers diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, improve producer efficiency, and ensure the quality and safety of milk. IDEXX also has an Other operating segment, which combines and presents its human medical diagnostic products and services business (OPTI Medical) and out-licensing arrangements. The company markets, sells, and services its products worldwide through its marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX maintains a sales presence in major regions worldwide including Africa, Asia Pacific, Canada, Europe, and Latin America. The company invests in research and development to introduce new products and services and enter new business areas. Research and development expenses were $191.0 million for the year ended December 31, 2023. IDEXX actively seeks patent protection for its inventions and licenses patents and technologies from third parties. Important patents and licenses include those related to Catalyst consumables, Catalyst instruments, reagents and methods for the detection of canine pancreatic lipase, and patents relating to reagents and methods for the detection of SDMA. For more information, visit IDEXX's website or contact the company at (207) 556-8100. IDEXX's ticker symbol is "IDXX" on the NASDAQ Global Select Market.

12 mos ending Dec 31, 201112 mos ending Dec 31, 201212 mos ending Dec 31, 201312 mos ending Dec 31, 201412 mos ending Dec 31, 201512 mos ending Dec 31, 201612 mos ending Dec 31, 201712 mos ending Dec 31, 201812 mos ending Dec 31, 201912 mos ending Dec 31, 202012 mos ending Dec 31, 202112 mos ending Dec 31, 202212 mos ending Dec 31, 20233 mos ending Mar 31, 20233 mos ending Mar 31, 2024CAGR %YoY %Revenue (+)
$1218.69
1293.34
1377.06
1485.81
1601.89
1775.42
1969.06
2213.24
2406.91
2706.66
3215.36
3367.32
3660.95
900.20
964.10
9.60%7.10%Cost of Revenue (-)
$572.18
594.19
620.94
669.69
711.62
799.99
871.68
971.70
1041.36
1135.62
1325.93
1362.99
1470.98
357.22
371.02
8.19%3.86%Gross Profit (+)
$646.51
699.15
756.12
816.12
890.27
975.44
1097.38
1241.54
1365.55
1571.04
1889.43
2004.34
2189.97
542.97
593.07
10.70%9.23%Selling, General & Administrative (-)
$334.24
354.57
401.35
457.60
482.46
524.08
575.17
632.34
679.51
735.27
796.39
850.75
901.89
217.91
241.48
8.62%10.82%Research & Development (-)
$76.04
82.01
88.00
98.26
99.68
101.12
109.18
117.86
133.19
141.25
161.01
254.82
190.95
44.67
52.63
7.97%17.84%Non-recurring Operating Expenses (-)
$
8.21
Operating Expenses (-)
$410.28
436.58
489.36
555.86
590.36
625.20
684.35
750.21
812.70
876.52
957.40
1105.57
1092.84
262.57
294.11
8.51%12.01%Costs & Expenses (Total) (-)
$982.46
1030.78
1110.30
1225.55
1301.98
1425.18
1556.03
1721.91
1854.06
2012.13
2283.33
2468.56
2563.82
619.80
665.14
8.32%7.32%Operating Income/Loss (+)
$236.22
262.56
266.76
260.25
299.91
350.24
413.03
491.33
552.85
694.52
932.03
898.76
1097.13
280.40
298.96
13.65%6.62%Interest Expense (-)
$3.55
3.85
5.39
15.43
29.24
32.05
37.23
34.74
31.05
33.13
29.81
39.86
41.58
13.13
7.91
22.77%-39.73%Earnings before Tax (+)
$234.42
260.62
263.26
246.56
273.14
321.85
381.06
457.74
522.22
661.99
902.65
859.97
1061.18
267.69
295.48
13.41%10.38%Tax Expense (-)
$72.67
82.33
75.47
64.60
81.01
99.79
117.79
80.69
94.43
79.85
157.81
180.88
216.13
53.63
59.90
9.51%11.68%Income/Loss (Continuing Operations) (+)
$161.75
178.29
187.79
181.95
192.14
222.05
263.27
377.05
427.79
582.13
744.84
679.09
845.04
214.05
235.58
14.77%10.06%Profit/Loss (+)
$161.75
178.29
187.79
181.95
192.13
222.05
263.27
377.05
427.79
582.13
744.84
679.09
845.04
14.77%Net Income/Loss (NCI) (-)
$-0.03
0.02
-0.01
0.04
0.06
0.01
0.13
0.02
0.07
0.35
-0.00
Net Income/Loss (+)
$161.79
178.27
187.80
181.91
192.08
222.04
263.14
377.03
427.72
581.78
744.85
679.09
845.04
214.05
235.58
14.77%10.06%Net Income/Loss (Common) (+)
$161.79
178.27
187.80
181.91
192.08
222.04
263.14
377.03
427.72
581.78
744.85
679.09
845.04
214.05
235.58
14.77%10.06%EPS (Basic)
$2.85
3.24
3.53
3.63
2.07
2.47
3.00
4.34
4.97
6.82
8.74
8.12
10.17
2.58
2.84
11.18%10.08%EPS (Diluted)
$2.78
3.17
3.48
3.58
2.05
2.44
2.94
4.26
4.89
6.71
8.60
8.03
10.06
2.55
2.81
11.31%10.20%Weighted Avg Shares (Basic)
56.79
54.98
53.16
50.05
92.60
89.73
87.77
86.86
86.11
85.34
85.20
83.62
83.07
82.99
83.10
3.22%0.13%Weighted Avg Shares (Diluted)
58.21
56.16
53.98
50.75
93.65
90.88
89.57
88.47
87.54
86.72
86.57
84.60
83.98
83.96
83.96
3.10%-0.00%Cash
$183.90
223.99
279.06
322.54
128.99
154.90
187.68
123.79
90.33
383.93
144.45
112.55
453.93
111.37
397.43
7.82%256.87%Short-term Investments
$
213.59
236.95
284.25
Receivables
$141.28
138.32
158.04
152.38
188.32
204.49
234.60
248.85
269.31
331.43
368.35
400.62
457.44
446.02
507.21
10.29%13.72%Inventory
$133.10
140.95
133.43
160.34
188.83
158.03
164.32
173.30
195.02
209.87
269.03
367.82
380.28
391.01
390.60
9.14%-0.11%Other Assets (Current)
$65.96
66.28
82.18
124.14
101.90
91.21
101.14
108.22
124.98
137.51
173.82
220.49
203.59
201.04
206.73
9.85%2.83%Assets (Current)
$524.23
569.54
652.71
759.40
821.63
845.58
971.99
654.17
679.64
1062.74
955.65
1101.48
1495.25
1149.45
1501.97
9.13%30.67%Property, Plant & Equipment (Net)
$216.78
245.18
281.21
303.59
333.03
357.42
379.10
437.27
614.45
646.34
692.77
768.09
817.68
780.50
828.61
11.70%6.16%Goodwill & Intangibles
$241.82
237.83
239.36
249.57
234.84
224.38
243.72
256.31
298.19
295.89
458.38
459.47
450.46
457.30
524.02
5.32%14.59%Other Assets
$47.99
51.06
57.23
71.65
85.49
103.31
118.62
189.59
240.19
289.60
330.40
417.73
496.53
421.15
498.91
21.50%18.46%Assets (Non-current)
$506.59
534.07
577.81
624.81
653.36
685.12
741.43
883.18
1152.84
1231.82
1481.55
1645.29
1764.67
1658.95
1851.54
10.96%11.61%Assets (Total)
$1030.81
1103.60
1230.52
1384.21
1474.99
1530.70
1713.42
1537.35
1832.47
2294.56
2437.20
2746.76
3259.93
2808.40
3353.51
10.07%19.41%Accounts Payable
$177.93
173.03
178.86
240.09
258.18
296.19
320.39
330.22
395.11
490.21
575.05
543.88
589.36
521.30
593.71
10.50%13.89%Debt (Current)
$243.92
213.11
278.04
549.00
573.00
611.00
655.00
398.94
288.76
49.99
148.50
653.98
325.00
506.49
325.00
2.42%-35.83%Other Liabilities (Current)
$15.03
20.19
21.46
31.81
25.58
27.38
29.18
41.29
41.46
42.57
40.03
37.94
37.20
37.84
38.19
7.84%0.94%Liabilities (Current)
$436.88
406.33
478.35
820.91
856.76
934.57
1004.57
770.44
725.34
582.76
763.58
1235.80
951.55
1065.63
956.90
6.70%-10.20%Debt (Non-current)
$2.50
1.39
150.36
350.00
597.09
593.11
606.08
601.35
766.38
858.49
775.21
694.39
622.88
696.36
620.78
58.38%-10.85%Other Liabilities
$51.84
59.62
83.59
95.72
105.14
111.24
156.62
174.79
162.93
220.51
208.43
207.84
200.97
205.31
206.93
11.95%0.79%Liabilities (Non-current)
$54.34
61.01
233.95
445.72
702.23
704.35
762.69
776.14
929.31
1079.01
983.63
902.23
823.85
901.67
827.71
25.43%-8.20%Liabilities (Total)
$491.22
467.35
712.30
1266.62
1558.99
1638.92
1767.26
1546.58
1654.65
1661.77
1747.21
2138.03
1775.39
1967.30
1784.61
11.30%-9.29%Treasury Stock
$1320.38
1457.18
1829.38
2453.27
1316.42
1633.44
1911.53
2288.90
2600.54
2799.89
3570.69
4392.11
4474.68
4401.67
4651.87
10.71%5.68%Retained Earnings
$1127.33
1305.59
1493.39
1675.30
318.36
540.40
803.54
1167.93
1595.65
2175.59
2920.44
3599.53
4444.57
3813.58
4680.15
12.11%22.72%AOCI
$15.44
15.95
13.62
-8.07
-42.27
-43.05
-36.47
-41.79
-46.18
-53.62
-53.48
-77.80
-71.21
-76.61
-80.40
-4.94%Shareholder's Equity
$539.59
636.26
518.21
117.59
-84.00
-108.21
-53.84
-9.23
177.82
632.79
689.99
608.74
1484.53
841.10
1568.91
8.80%86.53%Liabilities & Equity
$1030.81
1103.60
1230.52
1384.21
1474.99
1530.70
1713.42
1537.35
1832.47
2294.56
2437.20
2746.76
3259.93
2808.40
3353.51
10.07%19.41%Net Income/Loss
$161.75
178.29
187.79
181.95
192.13
222.05
263.27
377.05
427.79
582.13
744.84
679.09
845.04
214.05
235.58
14.77%10.06%Depreciation & Amortization
$48.20
52.41
54.60
58.89
70.39
79.06
83.18
83.17
88.01
96.00
104.60
111.90
114.91
28.33
29.90
7.51%5.55%Increase/Decrease in Working Capital
$-6.16
-2.45
2.62
9.72
69.81
-3.00
-8.38
91.64
104.97
31.76
137.52
273.53
72.43
70.61
81.42
15.31%Share-based Compensation
$15.50
15.95
16.54
18.10
19.88
19.89
23.52
25.16
39.28
30.95
37.76
49.77
59.74
13.93
14.40
11.90%3.37%Adjustments to Reconcile Net Income
$58.95
52.00
58.20
53.90
24.23
112.52
110.01
23.04
31.37
65.93
10.70
-136.10
61.47
-30.14
-36.99
0.35%-22.73%Net Cash (Operating)
$220.70
230.28
246.00
235.85
216.36
334.57
373.28
400.08
459.16
648.06
755.55
542.98
906.51
183.91
198.59
12.49%7.98%Capital Expenditure
$97.00
66.01
86.06
85.81
93.22
66.75
91.28
145.44
205.53
108.46
292.97
170.35
133.63
39.51
107.27
2.71%171.50%Net Cash (Investing)
$-97.00
-66.00
-86.06
-80.41
-308.41
-90.79
-138.69
138.60
-205.53
-109.38
-292.97
-195.35
-125.25
-39.51
-106.94
-170.67%Increase/Decrease in Debt
$113.04
-31.92
213.89
470.61
274.10
38.00
44.00
-256.04
-10.28
-89.63
23.50
430.50
-404.00
-147.50
Increase/Decrease in Equity
$-226.70
-108.10
-329.53
-588.72
-379.58
-265.80
-243.94
-331.12
-265.71
-136.51
-702.86
-784.40
-24.89
12.80
-133.89
-1146.30%Interest Expenses
$3.76
3.94
5.02
12.28
27.19
Net Cash (Financing)
$-97.66
-125.34
-102.45
-103.44
-95.55
-217.82
-208.02
-597.80
-286.41
-248.42
-697.41
-370.94
-442.00
-146.08
-144.07
1.37%Cash Taxes Paid
$44.35
68.92
67.72
60.24
54.88
7.20
13.23
83.79%Effect of Exchange Rate
$0.93
1.16
-2.41
-8.52
-5.95
-0.05
6.20
-4.77
-0.69
3.33
-4.64
-8.61
2.13
0.50
-4.07
7.10%-911.58%Increase/Decrease in Cash
$26.98
40.09
55.07
43.48
-193.54
25.91
32.77
-63.88
-33.47
293.60
-239.47
-31.91
341.39
-1.18
-56.50
23.55%-4692.11%Cash (Beginning)
$156.91
183.90
223.99
279.06
322.54
128.99
154.90
187.68
123.79
90.33
383.93
144.45
112.55
112.55
453.93
-2.73%303.33%Cash (Ending)
$183.90
223.99
279.06
322.54
128.99
154.90
187.68
123.79
90.33
383.93
144.45
112.55
453.93
111.37
397.43
7.82%256.87%NOPAT
$191.54
193.13
198.14
196.67
239.66
241.64
285.36
404.72
452.88
610.74
769.08
709.72
873.67
272.86
285.57
13.48%4.66%Gross Margin %
53.05%
54.06%
54.91%
54.93%
55.58%
54.94%
55.73%
56.10%
56.73%
58.04%
58.76%
59.52%
59.82%
60.32%
61.52%
Operating Margin %
19.38%
20.30%
19.37%
17.52%
18.72%
19.73%
20.98%
22.20%
22.97%
25.66%
28.99%
26.69%
29.97%
31.15%
31.01%
NOPAT Margin %
15.72%
14.93%
14.39%
13.24%
14.96%
13.61%
14.49%
18.29%
18.82%
22.56%
23.92%
21.08%
23.86%
30.31%
29.62%
Net Margin %
13.28%
13.78%
13.64%
12.24%
11.99%
12.51%
13.36%
17.04%
17.77%
21.49%
23.17%
20.17%
23.08%
23.78%
24.44%
Tax Rate %
18.92%
26.45%
25.72%
24.43%
20.09%
31.01%
30.91%
17.63%
18.08%
12.06%
17.48%
21.03%
20.37%
2.69%
4.48%
ROA
18.58%
17.50%
16.10%
14.21%
16.25%
15.79%
16.65%
26.33%
24.71%
26.62%
31.56%
25.84%
26.80%
9.72%
8.52%
ROE
35.50%
30.35%
38.24%
167.25%
-285.32%
-223.30%
-529.99%
-4383.38%
254.68%
96.52%
111.46%
116.59%
58.85%
32.44%
18.20%
ROIC
28.61%
27.26%
26.07%
25.93%
29.84%
30.61%
32.63%
45.54%
43.07%
49.15%
57.48%
45.92%
46.87%
16.79%
16.47%
Asset Turnover
1.18
1.17
1.12
1.07
1.09
1.16
1.15
1.44
1.31
1.18
1.32
1.23
1.12
0.32
0.29
Inventory Turnover
4.30
4.22
4.65
4.18
3.77
5.06
5.30
5.61
5.34
5.41
4.93
3.71
3.87
0.91
0.95
Equity Multiplier
1.91
1.73
2.37
11.77
-17.56
-14.15
-31.82
-166.51
10.30
3.63
3.53
4.51
2.20
3.34
2.14
Current Ratio
1.20
1.40
1.36
0.93
0.96
0.90
0.97
0.85
0.94
1.82
1.25
0.89
1.57
1.08
1.57
Quick Ratio
0.74
0.89
0.91
0.58
0.62
0.64
0.70
0.48
0.50
1.23
0.67
0.42
0.96
0.52
0.95
Debt/Equity Ratio
0.46
0.34
0.83
7.65
-13.93
-11.13
-23.42
-108.34
5.93
1.44
1.34
2.22
0.64
1.43
0.60
Interest Coverage Ratio
62.78
66.57
53.10
21.19
11.03
Working Capital/Sales
0.17
0.17
0.17
0.14
0.15
0.12
0.13
0.09
0.06
0.11
0.06
0.09
0.16
0.43
0.40
R&D/Sales
0.06
0.06
0.06
0.07
0.06
0.06
0.06
0.05
0.06
0.05
0.05
0.08
0.05
0.05
0.05
Total Payout
$117.43
143.96
120.66
130.39
132.67
227.80
199.94
587.16
275.98
226.14
679.36
353.90
428.89
134.70
133.89
11.40%-0.61%Payout Ratio %
61.31%
74.54%
60.89%
66.30%
55.36%
94.27%
70.07%
145.08%
60.94%
37.03%
88.33%
49.86%
49.09%
49.37%
46.88%